Chih-Chi Hu

744 total citations · 1 hit paper
7 papers, 520 citations indexed

About

Chih-Chi Hu is a scholar working on Immunology, Epidemiology and Rheumatology. According to data from OpenAlex, Chih-Chi Hu has authored 7 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in Chih-Chi Hu's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Infectious Diseases and Tuberculosis (1 paper). Chih-Chi Hu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Infectious Diseases and Tuberculosis (1 paper). Chih-Chi Hu collaborates with scholars based in United States, Germany and South Africa. Chih-Chi Hu's co-authors include Louise Kuhn, Thomas C. Wright, Wei‐Yann Tsai, Lynette Denny, Michael E. Wechsler, Hélène Goulaouic, Elliot Israel, Andreas Jessel, Nikhil Amin and Renata Martincova and has published in prestigious journals such as New England Journal of Medicine, JAMA and JNCI Journal of the National Cancer Institute.

In The Last Decade

Chih-Chi Hu

7 papers receiving 505 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

2021 258 citations Michael E. Wechsler, Marcella Ruddy et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Chih-Chi Hu

Since Specialization

Citations

This map shows the geographic impact of Chih-Chi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Chi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Chi Hu more than expected).

Fields of papers citing papers by Chih-Chi Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Chi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Chi Hu. The network helps show where Chih-Chi Hu may publish in the future.

Co-authorship network of co-authors of Chih-Chi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-Chi Hu. A scholar is included among the top collaborators of Chih-Chi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-Chi Hu. Chih-Chi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	A Study of Dupilumab in Adults with CRSsNP: Results from the Liberty ORION study 2025 ·Journal of Allergy and Clinical Immunology ·Stella E. Lee, Amber Luong, Anju T. Peters, Philippe Gevaert, Joseph Han, Claus Bachert, Chih-Chi Hu, Jennifer Maloney, (unknown), (unknown), Andrew P. Fontenot, (unknown)	1
2	Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis 2023 ·Lara D. Veeken ·Gerd R Burmester, Vibeke Strand, Alan Kivitz, Chih-Chi Hu, Sheldon Wang, Hubert van Hoogstraten, (unknown), Roy Fleischmann	8
3	Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma breakdown → 2021 ·New England Journal of Medicine ·Michael E. Wechsler, Marcella Ruddy, Ian Pavord, Elliot Israel, Klaus F. Rabe, Linda B. Ford, Jorge Máspero, Raolat M. Abdulai, Chih-Chi Hu, Renata Martincova, Andreas Jessel, Michael C. Nivens, Nikhil Amin, David M. Weinreich, George D. Yancopoulos, Hélène Goulaouic	258
4	214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis 2018 ·Lara D. Veeken ·Gerd R Burmester, Stefano Fiore, Chih-Chi Hu, (unknown), Eun Bong Lee, Mark C. Genovese	1
5	Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor–Based Viral Suppression 2010 ·JAMA ·Ashraf Coovadia, Elaine J. Abrams, (unknown), Tammy Meyers, (unknown), Gayle Sherman, Gillian Hunt, Chih-Chi Hu, Wen–Yu Tsai, Lynn Morris, Louise Kuhn	66
6	Human Papillomavirus–Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial 2010 ·JNCI Journal of the National Cancer Institute ·Lynette Denny, Louise Kuhn, Chih-Chi Hu, Wei‐Yann Tsai, Thomas C. Wright	124
7	Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy 2009 ·AIDS ·Kelly M. Smith, Louise Kuhn, Ashraf Coovadia, Tammy Meyers, Chih-Chi Hu, (unknown), (unknown), Renate Strehlau, Gayle Sherman, Elaine J. Abrams	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact